Harnessing the Antibacterial Potential of Star Fruit Extract against MRSA: Metabolic Profiling, Molecular Docking, and In Vitro Wound-Healing Effects.
Eraqi Walaa A WA, Mohamed Sally A SA, Hanafi Maha M, Salem Mohamed A MA et al.
Averrhoa carambola L. (star fruit) is recognized for its nutritional value and bioactive constituents. This study investigated its antibacterial and antibiofilm activities against methicillin-resistant Staphylococcus aureus (MRSA) and its potential to promote wound healing. The in vitro antibacterial activity of the extract was evaluated against six MRSA strains by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill kinetics. The extract exhibited a uniform MIC of 1.95 mg/mL against all tested MRSA strains, while MBC values ranged from 15.6 to 125 mg/mL. Biofilm inhibition was assessed using a crystal violet assay, while transmission electron microscopy and intracellular ion leakage analysis were used to investigate the antibacterial mechanism. The extract significantly inhibited biofilm formation at 0.5 × and 0.25 × MIC, particularly against MS3 and MS15 strains (p ≤ 0.05). The extract induced membrane damage and significant leakage of intracellular phosphate (p = 0.0036) and potassium (p = 0.0001). Its cytocompatibility and wound-healing activity were evaluated using primary human adult dermal fibroblasts (HDFa) and an in vitro scratch assay. The extract showed an EC50 of 2.96 mg/mL without reducing HDFa viability and significantly enhanced wound closure to 70%, compared with 82% for dexamethasone. UPLC-QTOF-MS/MS profiling identified 130 metabolites, with flavonoids representing the predominant class (49 compounds). Molecular docking further predicted favorable binding interactions between selected flavonoids and collagenase, elastase, and lipase. These findings demonstrate the antibacterial, antibiofilm, and in vitro wound-healing potential of star fruit extract against MRSA.